(CGM) Cegedim S.A. - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000053506
CGM: Software, Data, Healthcare, Insurance, Management, Services
Cegedim SA is a French technology and services company specializing in digital data flow management for the healthcare ecosystem and B2B sectors. It also operates as a business software publisher, catering to healthcare and insurance professionals across France, Europe, and internationally. The company is structured into two main segments: Health Insurance, HR, and e-Services, and Healthcare Professionals. The Health Insurance, HR, and e-Services division provides a range of solutions, including hosting services, HR and payroll management outsourcing, electronic data exchange, and data processing services, primarily targeting insurance companies, mutual insurers, personal protection insurers, and insurance brokers. It also facilitates interactions between these entities and healthcare professionals. The Healthcare Professionals segment offers management software, databases, and solutions tailored for doctors, allied health professionals, pharmacists, and healthcare facilities. Established in 1969, Cegedim SA is headquartered in Boulogne-Billancourt, France, and operates as a subsidiary of FCB SA.
The companys services and software solutions are designed to streamline operations, enhance efficiency, and ensure compliance with regulatory requirements in the healthcare and insurance industries. Its product portfolio includes tools for practice management, patient data management, and insurance claims processing. Cegedim SA also invests in innovation, particularly in areas such as artificial intelligence and data analytics, to support decision-making and improve patient outcomes. With a strong focus on digital transformation, the company has established itself as a key player in the European healthcare technology sector.
Additional Sources for CGM Stock
CGM Stock Overview
| Market Cap in USD | 200m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Technology |
| IPO / Inception |
CGM Stock Ratings
| Growth 5y | -61.4% |
| Fundamental | 15.5% |
| Dividend | 0.74% |
| Rel. Strength Industry | -18.9 |
| Analysts | - |
| Fair Price Momentum | 11.27 EUR |
| Fair Price DCF | 112.11 EUR |
CGM Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 44.1% |
CGM Growth Ratios
| Growth Correlation 3m | 25.4% |
| Growth Correlation 12m | -55.6% |
| Growth Correlation 5y | -88.8% |
| CAGR 5y | -9.77% |
| CAGR/Max DD 5y | -0.15 |
| Sharpe Ratio 12m | -0.11 |
| Alpha | -19.44 |
| Beta | -0.25 |
| Volatility | 27.34% |
| Current Volume | 2.5k |
| Average Volume 20d | 4.2k |
As of March 16, 2025, the stock is trading at EUR 13.25 with a total of 2,549 shares traded.
Over the past week, the price has changed by -1.12%, over one month by +0.38%, over three months by -0.38% and over the past year by -18.21%.
Neither. Based on ValueRay Fundamental Analyses, Cegedim S.A. is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.54 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CGM as of March 2025 is 11.27. This means that CGM is currently overvalued and has a potential downside of -14.94%.
Cegedim S.A. has no consensus analysts rating.
According to ValueRays Forecast Model, CGM Cegedim S.A. will be worth about 12.2 in March 2026. The stock is currently trading at 13.25. This means that the stock has a potential downside of -8.15%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 14.7 | 10.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 12.2 | -8.2% |